|
Thousands of breast cancer physicians and researchers from
around the world are heading to Texas this week for the annual San
Antonio Breast Cancer Symposium, held December 10-14. The event, now in
its 31st year, showcases the latest in breast cancer research. This
year, the American Association of Cancer Research (AACR) is co-sponsoring the show along with the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and the Baylor College of Medicine. The schedule features presentations in molecular science, breast cancer risk
assessment, and breast imaging technologies.
Get daily updates on the research being presented at the conference
from our content partners at CURE magazine. Click here and
on the links below to read the latest.
The Jury Is In: Aromatase Inhibitors Are More Effective Than Tamoxifen
Dec. 12, 2008
Low-Dose Estradiol as Effective as High Dose in Treating Aromatase Inhibitor-Resistant Breast Cancer
Dec. 12, 2008
The Implications of Micrometastases in Early-Stage Breast Cancer Revealed
Dec. 12, 2008
New
Ways of Studying Drugs Are Needed to Succeed in Developing New Agents
Dec. 11, 2008
SABCS
2008 Marks the First Year of Collaboration
Dec. 11, 2008
Advocates
Converge at Breast Cancer Conference
Dec. 10, 2008
A
Recap of Last Year's Symposium
Dec. 10, 2008
ACS News Center stories are provided as a source of cancer-related
news and are not intended to be used as
press releases.
|